Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 SUR receptor activity vs. incidence of hypoglycaemia and cardiovascular mortality with sulphonylurea therapy for diabetics.

× No keyword cloud information.

4 in total

Review 1. [Diabetic kidney disease - Update 2016].

Authors: Harald Sourij; Roland Edlinger; Friedrich Prischl; Martin Auinger; Alexandra Kautzky-Willer; Marcus D Säemann; Rudolf Prager; Martin Clodi; Guntram Schernthaner; Gert Mayer; Rainer Oberbauer; Alexander R Rosenkranz
Journal: Wien Klin Wochenschr Date: 2016-04 Impact factor: 1.704

2. The risk of overall mortality in patients with type 2 diabetes receiving glipizide, glyburide, or glimepiride monotherapy: a retrospective analysis.

Authors: Kevin M Pantalone; Michael W Kattan; Changhong Yu; Brian J Wells; Susana Arrigain; Anil Jain; Ashish Atreja; Robert S Zimmerman
Journal: Diabetes Care Date: 2010-03-09 Impact factor: 19.112

Review 3. Experience with DPP-4 inhibitors in the management of patients with type 2 diabetes fasting during Ramadan.

Authors: Anja Schweizer; Serge Halimi; Sylvie Dejager
Journal: Vasc Health Risk Manag Date: 2013-12-24

4. A double-blind, randomized trial, including frequent patient-physician contacts and Ramadan-focused advice, assessing vildagliptin and gliclazide in patients with type 2 diabetes fasting during Ramadan: the STEADFAST study.

Authors: Mohamed Hassanein; Khalifa Abdallah; Anja Schweizer
Journal: Vasc Health Risk Manag Date: 2014-05-28

4 in total